Intensive Care Unit ICUBRILSNCT06697340
Braden Pressure Ulcer Scale for Prediction of the Intensive Care Length of Stay
An observational study of Intensive Care Unit ICU and Length of ICU Stay, run by Ankara City Hospital Bilkent at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to predict the length of intensive care unit stay of patients treated in a tertiary general intensive care unit with the help of the Braden risk assesment scale, which is used to predict the risk of pressure ulcers. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Intensive Care Unit ICU, Length of ICU Stay, Pressure Ulcer Risk
- How many people
- 11,000 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jan 2025to 31 May 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Medical and surgical intensive care patients admitted to the tertiary general intensive care unit of Ankara Bilkent City Hospital
Who may be able to join
- Patients older than 18 years
- Patients treated in intensive care
- Patients treated with diagnoses other than Covid-19
- Patients without missing data in the hospital electronic data system
- Patients hospitalized for more than 24 hours
Who cannot join
- Patients younger than 18 years
- Patients treated for Covid-19 disease
- Patients with missing data in the hospital electronic data system
- Patients hospitalized for less than 24 hours
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of the Braden Pressure Ulcer Scale on the Prediction of Intensive Care Unit Length of Stay
The aim of this study is to predict the length of intensive care unit stay of patients treated in a tertiary general intensive care unit with the help of the Braden risk assesment scale, which is used to predict the risk of pressure ulcers. The main question it aims to answer is:
- Does high Braden scales predict the long lenght of stay? Braden scales of patients admitted to the intensive care unit were recorded every day.
Read the detailed description
Intensive care units are specialized units where patients with multiple comorbidities are treated. The length of stay in intensive care varies according to the characteristics of the patient, the disease and the center. Prolonged intensive care stay causes an increase in mortality . It has been reported that the severity of the disease as well as the comorbidities of the patients contribute to prolonged stay . One third of patients with stay longer than seven days were evaluated as more fragile than before hospital admission. Prolonged intensive care length of stay leads to an increase in morbidity and mortality, bed demand and costs.
The Braden pressure ulcer scale was developed by Braden et al. in 1987 . Scoring is done under six different headings evaluating sensory perception, humidity, activity, mobility, nutrition and friction/cutting. It has been reported as an effective tool for evaluating pressure ulcer development in intensive care patients. In this scoring system, there are different assessment steps such as mobility, nutrition, sensory perception, etc., which allows the assessment of the functional capacity of the patients at the time of admission. In a study of elderly dementia patients, the Braden scale was found to be effective in predicting 90-day mortality. In a retrospective evaluation of patients with heart failure, the Braden scale was reported to predict 30-day mortality.
The aim of our study is to predict the length of intensive care stay by analyzing the Braden scales calculated on the day of hospitalization.
- Conditions
- Intensive Care Unit ICU, Length of ICU Stay, Pressure Ulcer Risk, Scale Reliability Validity
- Keywords
- Braden risk assesment scale, Length of stay, ICU
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Group I | Intensive Care patients admitted to tertiary intensive care unit and treated more than 24 hours |
What is being measured
The primary outcome is the main question the study is designed to answer.
Intensive care length of stay
Patient intensive care length of stay
Measured: Time period between patient admission to intensive care unit and patient discharge, patient transfer to ward or patient death, whichever came first. Estimated time up to 52 weeks
Secondary outcomes (1)
Mortality
All-cause mortality rate in the intensive care unit.
Measured: Time interval between patient intensive care unit admission to patient mortality. Estimated time is up to 52 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Nov 2024
- Study start1 Jan 2025
- Primary completion31 May 2025
- Study completion31 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Intensive Care Unit ICUStudies of the same condition, open and under way.
- More trials run by Ankara City Hospital BilkentThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 11,000 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ankara City Hospital Bilkent
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Cihangir Doğu, Ankara City Hospital Bilkent
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06697340
- Sponsor's protocol ID
- TABED 2-24-618
- Acronym
- BRILS
- Status last verified
- Jan 2025
- First submitted
- 15 Nov 2024
- Last updated
- 28 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Cheng H, Ling Y, Li Q, Tang Y, Li X, Liang X, Huang X, Su L, Lyu J. ICU admission Braden score independently predicts delirium in critically ill patients with ischemic stroke. Intensive Crit Care Nurs. 2024 Jun;82:103626. doi: 10.1016/j.iccn.2024.103626. Epub 2024 Jan 13.
PubMed 38219301Cheng H, Li X, Liang X, Tang Y, Wei F, Wang Z, Lyu J, Wang Y. Braden score can independently predict 90-day mortality in critically ill patients with dementia. Int J Geriatr Psychiatry. 2024 May;39(5):e6093. doi: 10.1002/gps.6093.
PubMed 38752607Bandle B, Ward K, Min SJ, Drake C, McIlvennan CK, Kao D, Wald HL. Can Braden Score Predict Outcomes for Hospitalized Heart Failure Patients? J Am Geriatr Soc. 2017 Jun;65(6):1328-1332. doi: 10.1111/jgs.14801. Epub 2017 Feb 21.
PubMed 28221672
Study at a glance
From the registry record, last updated by the sponsor on 28 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of the Braden Pressure Ulcer Scale on the Prediction of Intensive Care Unit Length of Stay
- ClinicalTrials.gov ID
- NCT06697340
- Acronym / sponsor ID
- BRILS / TABED 2-24-618
- Conditions
- Intensive Care Unit ICU, Length of ICU Stay, Pressure Ulcer Risk, Scale Reliability Validity
- Keywords
- Braden risk assesment scale, Length of stay, ICU
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 11,000 participants (actual)
- Lead sponsor
- Ankara City Hospital BilkentUniversity, hospital or other
- Study start
- 1 Jan 2025 (actual)
- Primary completion
- 31 May 2025 (actual)
- Study completion
- 31 May 2025 (actual)
- First posted
- 20 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to predict the length of intensive care unit stay of patients treated in a tertiary general intensive care unit with the help of the Braden risk assesment scale, which is used to predict the risk of pressure ulcers. The main question it aims to answer is:
- Does high Braden scales predict the long lenght of stay? Braden scales of patients admitted to the intensive care unit were recorded every day.
Detailed description
Intensive care units are specialized units where patients with multiple comorbidities are treated. The length of stay in intensive care varies according to the characteristics of the patient, the disease and the center. Prolonged intensive care stay causes an increase in mortality . It has been reported that the severity of the disease as well as the comorbidities of the patients contribute to prolonged stay . One third of patients with stay longer than seven days were evaluated as more fragile than before hospital admission. Prolonged intensive care length of stay leads to an increase in morbidity and mortality, bed demand and costs.
The Braden pressure ulcer scale was developed by Braden et al. in 1987 . Scoring is done under six different headings evaluating sensory perception, humidity, activity, mobility, nutrition and friction/cutting. It has been reported as an effective tool for evaluating pressure ulcer development in intensive care patients. In this scoring system, there are different assessment steps such as mobility, nutrition, sensory perception, etc., which allows the assessment of the functional capacity of the patients at the time of admission. In a study of elderly dementia patients, the Braden scale was found to be effective in predicting 90-day mortality. In a retrospective evaluation of patients with heart failure, the Braden scale was reported to predict 30-day mortality.
The aim of our study is to predict the length of intensive care stay by analyzing the Braden scales calculated on the day of hospitalization.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Group I | – | –Intensive Care patients admitted to tertiary intensive care unit and treated more than 24 hours |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Medical and surgical intensive care patients admitted to the tertiary general intensive care unit of Ankara Bilkent City Hospital
Key inclusion criteria (5 listed)
- Patients older than 18 years
- Patients treated in intensive care
- Patients treated with diagnoses other than Covid-19
- Patients without missing data in the hospital electronic data system
- Patients hospitalized for more than 24 hours
Key exclusion criteria (4 listed)
- Patients younger than 18 years
- Patients treated for Covid-19 disease
- Patients with missing data in the hospital electronic data system
- Patients hospitalized for less than 24 hours
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Intensive care length of stay
Time frame: Time period between patient admission to intensive care unit and patient discharge, patient transfer to ward or patient death, whichever came first. Estimated time up to 52 weeks
Patient intensive care length of stay
1 secondary outcome
Mortality
Time frame: Time interval between patient intensive care unit admission to patient mortality. Estimated time is up to 52 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jul 2025.
- Background: PubMed 38219301Cheng H, Ling Y, Li Q, Tang Y, Li X, Liang X, Huang X, Su L, Lyu J. ICU admission Braden score independently predicts delirium in critically ill patients with ischemic stroke. Intensive Crit Care Nurs. 2024 Jun;82:103626. doi: 10.1016/j.iccn.2024.103626. Epub 2024 Jan 13.
- Background: PubMed 38752607Cheng H, Li X, Liang X, Tang Y, Wei F, Wang Z, Lyu J, Wang Y. Braden score can independently predict 90-day mortality in critically ill patients with dementia. Int J Geriatr Psychiatry. 2024 May;39(5):e6093. doi: 10.1002/gps.6093.
- Background: PubMed 28221672Bandle B, Ward K, Min SJ, Drake C, McIlvennan CK, Kao D, Wald HL. Can Braden Score Predict Outcomes for Hospitalized Heart Failure Patients? J Am Geriatr Soc. 2017 Jun;65(6):1328-1332. doi: 10.1111/jgs.14801. Epub 2017 Feb 21.
- Individual participant dataSharing planned: No
Related trials for Intensive Care Unit ICU
Recruiting
Effect of Rutin and Vitamin C on Outcomes in Adults With Sepsis Admitted to the Intensive Care Unit
Sepsis
Not yet recruitingObservational study
CAROTID DOPPLER AND CEREBRAL OXIMERY IN POST CARDIAC ARREST ICU PATIENTS
Cardiac Arrest (CA), Carotid Doppler
Not yet recruitingPhase 4
Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia
Community Acquired Pneumonia (CAP)
RecruitingPhase 3
Canadian Critical Care Comparative Effectiveness Platform
Intensive Care Unit ICU, Vasopressor
Active, not recruiting
Weighted Blankets for Agitation in Adults in the Intensive Care Unit
Psychomotor Agitation, Critical Illness
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Intensive Care Unit ICU and Length of ICU Stay, run by Ankara City Hospital Bilkent at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Intensive care length of stay (time frame: Time period between patient admission to intensive care unit and patient discharge, patient transfer to ward or patient death, whichever came first. Estimated time up to 52 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06697340, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2025.